Pfizer-BioNTech Seek Emergency Use Authorization Of Bivalent COVID-19 Vaccine As Booster Dose In Children Under Five Years

Reuters (3/1, Roy) reports Pfizer and BioNTech “have applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine in the United States as a booster dose for children aged six months through four years, the companies said on Wednesday....